H.R. 9268 aims to amend the Bank Secrecy Act by requiring operators of digital asset kiosks to register with authorities. Additionally, these operators will be mandated to follow anti-money laundering (AML) and anti-fraud regulations, ensuring that transactions conducted through these kiosks are monitored and compliant with existing financial laws.
Supporters of H.R. 9268 have praised the bill as a necessary step to enhance financial security and prevent illicit activities associated with digital assets. They argue that the registration and compliance requirements will help protect consumers and promote transparency in the rapidly evolving digital asset market.
Critics of H.R. 9268 have expressed concerns that the new regulations may stifle innovation and create burdensome compliance costs for digital asset kiosk operators. Some argue that the bill could hinder the growth of the digital asset industry in the U.S. and limit access for consumers looking to utilize these services.
The analysis of H.R. 9268, which aims to amend the Bank Secrecy Act regarding digital asset kiosk operators, reveals no direct industry overlaps between the sponsor Sean Casten's top donor industries and the bill's subject matter. The top donor industries do not appear to have a vested interest in digital assets or the regulation of anti-money laundering and anti-fraud requirements. Furthermore, the lobbying activity related to this bill's policy area includes contributions from various health and infrastructure-related entities, which do not directly correlate with the digital asset industry. The largest single contribution in this context comes from Vertex Pharmaceuticals Incorporated, which contributed $60,000, but this does not suggest a direct conflict given the nature of the bill. Therefore, the risk of conflict of interest is assessed as low.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | MARSHALL & POPP, LLC | $60,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | MARSHALL & POPP, LLC | $60,000 |
| INTERMOUNTAIN HEALTH | MCDERMOTT WILL & SCHULTE LLP | $50,000 |
| WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) | RED MAPLE CONSULTING, LLC | $40,000 |
| FRONTIER INFRASTRUCTURE HOLDINGS LLC | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| ECKERD CONNECTS | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| SMART APPROACHES TO MARIJUANA | OFF HILL STRATEGIES L.L.C. | $20,000 |
| FEDERATION OF ELECTRIC POWER COS OF JAPAN | GEORGE H. DENISON | $10,000 |
| MAYO CLINIC | MCDERMOTT WILL & SCHULTE LLP | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG TEN CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG 12 CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| SOUTHEASTERN CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| PAC-12 CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| ATLANTIC COAST CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Sean Casten, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
